Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.
about
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant CyclophosphamideAlternative Donor Transplantation for Acute Myeloid LeukemiaHaploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectivesHaplo is the new black.Density gradient centrifugation compromises bone marrow mononuclear cell yield.Role of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia.Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies.γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytesDonor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation setsAnti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftmentHaploidentical transplantation for hematologic malignancies: where do we stand?Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.Strategies in haploidentical stem cell transplantation in adults.The role of KIR genes and ligands in leukemia surveillance.The current role of T cell depletion in paediatric stem cell transplantation.At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers.T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.Haploidentical stem cell transplantation for the treatment of leukemia: current status."No donor"? Consider a haploidentical transplantThe evolution of T-cell depletion in haploidentical stem-cell transplantation.Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.Haploidentical, unmanipulated G-CSF-primed peripheral blood stem cell transplantation for high-risk hematologic malignancies: an update.Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation.Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update.Optimization of individualized graft composition: CD3/CD19 depletion combined with CD34 selection for haploidentical transplantation.Haploidentical HSCT: a 15-year experience at San Raffaele.Advances in haploidentical stem cell transplantation for hematologic malignancies.Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease.Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study
P2860
Q26748867-25C6D5B5-CAA8-4279-B6B6-FFDE00A6B421Q26767438-10965526-828E-4224-B96F-D262F12114FDQ26799456-68A60170-264D-4069-9ADB-4F6DB50080FBQ28080452-C8A4B61E-DD55-4F03-A25B-E965BD453209Q33987066-4368AC5C-68C6-4D32-A109-46F6AA3C3855Q34510325-D1CEA338-84CD-4D38-A5FA-67D23C812640Q34532041-240DECDA-A10B-41DB-9112-37591BA0DDD6Q35083562-F9EEEFDE-1F94-4E1F-9A83-EE7CB05D985BQ35634919-39D396C7-578E-4437-8F12-7BEF02BDAEB5Q35834570-1EE3D641-E0BE-4F32-A3B6-518536FE78A1Q36488985-D7600B74-C28B-4FAF-BA98-DC94472515E8Q36854831-9A0A1AFB-8B4F-494C-BD3F-B7F01D2F8974Q37029856-60AFDB13-0823-4B99-95C4-75A5A19B4AA3Q37418956-601ADF2D-726F-43F4-9D60-E4B9CD0EF0AAQ38081103-CEA98E7A-E890-4F6B-859C-3FBFE876841BQ38110308-2792997A-3D85-41DF-A046-6259AC0C6721Q38151057-F9070A3B-416F-4C42-80DB-97C22E600CD6Q38190856-3CAE220E-E45B-484F-B5AD-8D84185A5817Q38212957-BB5C4619-509F-435F-BB2D-26EBE48B1B7DQ38248521-C7D76E78-C23A-4752-B3D2-70D09154C706Q38259420-18EEADD1-4156-401E-84B6-6241630FDDEFQ38673780-63EA9389-BEF9-4ADD-88F8-3AFB90136EFDQ38742867-3A8F47AD-F89C-4CB2-8830-FA9BEF78698CQ39305147-34CDB275-484A-4665-803B-87F5C97B62DCQ39670316-0FCA1286-3F51-4306-AC14-5017BB61629DQ40313702-41100E32-824E-4E9D-9503-F86E01D55944Q41697458-5A186748-3C54-4A4A-A885-4828597A32C6Q50236616-8C63210B-91A3-41F6-B62A-0CFBD84AAEB3Q50548477-4102EFBE-6D48-4625-B109-6BB8B4CF3AD5Q51636737-6C021D66-3C54-40AF-938E-1E9EC5E76E39Q52763837-1D700B89-DC33-4E8B-92BB-035AD9C37ECCQ58781733-7BBF7AC2-062C-4C8A-9B59-E5FE8AF678CA
P2860
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Haploidentical allogeneic hema ...... onditioning: a phase II study.
@ast
Haploidentical allogeneic hema ...... onditioning: a phase II study.
@en
type
label
Haploidentical allogeneic hema ...... onditioning: a phase II study.
@ast
Haploidentical allogeneic hema ...... onditioning: a phase II study.
@en
prefLabel
Haploidentical allogeneic hema ...... onditioning: a phase II study.
@ast
Haploidentical allogeneic hema ...... onditioning: a phase II study.
@en
P2093
P2860
P1433
P1476
Haploidentical allogeneic hema ...... onditioning: a phase II study.
@en
P2093
Birgit Federmann
Christoph Faul
Christoph Meisner
Dietrich W Beelen
Gerhard Behre
Gernot Stuhler
Lambros Kordelas
Lothar Kanz
Matthias Stelljes
Maximilian Christopeit
P2860
P304
P356
10.3324/HAEMATOL.2011.059378
P577
2012-04-04T00:00:00Z